Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. (Q52858669)

9 May 2018

title

Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. (English)

1 reference

9 May 2018

main subject

cystic fibrosis

0 references

patient

0 references

Pseudomonas aeruginosa

1 reference

Tim W R Lee

1

1 reference

9 May 2018

Keith G Brownlee

2

1 reference

9 May 2018

Steven P Conway

3

1 reference

9 May 2018

Miles Denton

4

1 reference

9 May 2018

James M Littlewood

5

1 reference

9 May 2018

publication date

1 March 2003

1 reference

9 May 2018

Journal of Cystic Fibrosis

published in

1 reference

9 May 2018

volume

2

1 reference

9 May 2018

issue

1

1 reference

9 May 2018

page(s)

29-34

1 reference

9 May 2018

Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900141-8

7 January 2021

Effects of pseudomonas aeruginosa colonization on lung function and anthropometric variables in children with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900141-8

7 January 2021

Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900141-8

7 January 2021

Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900141-8

7 January 2021

The value of serum IgG titres against Pseudomonas aeruginosa in the management of early pseudomonal infection in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900141-8

7 January 2021

Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974-1995).

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900141-8

7 January 2021

Long-term follow up of changes in FEV1 and treatment intensity during Pseudomonas aeruginosa colonisation in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900141-8

7 January 2021

Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900141-8

7 January 2021

Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900141-8

7 January 2021

Antimicrobial treatment of pulmonary colonization and infection by pseudomonas aeruginosa in cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900141-8

7 January 2021

Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900141-8

7 January 2021

An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900141-8

7 January 2021

Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900141-8

7 January 2021

Sputum induction in young cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900141-8

7 January 2021

Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900141-8

7 January 2021

The chest radiograph in cystic fibrosis: a new scoring system compared with the Chrispin-Norman and Brasfield scores

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900141-8

7 January 2021

Body mass index reference curves for the UK, 1990

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900141-8

7 January 2021

Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900141-8

7 January 2021

Prospects for the prevention and control of pseudomonal infection in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900141-8

7 January 2021

Clinical studies of rhDNase in moderately and severely affected patients with cystic fibrosis--an overview

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2802%2900141-8

7 January 2021

10.1016/S1569-1993(02)00141-8

Identifiers

DOI

1 reference

9 May 2018

PubMed ID

15463843

1 reference

9 May 2018